Data is not available at this time.
Glory Health Industry Limited operates as a real estate developer in China, focusing on the development and sale of commercial and residential properties. The company's core revenue model is built on property sales, supplemented by land development services for local governments, property rental income, and management fees. It serves both individual residential buyers and corporate clients for commercial properties, positioning itself within the highly competitive and cyclical Chinese real estate sector. The company, headquartered in Beijing and founded in 1994, is a subsidiary of Alltogether Land Company Limited, which provides a degree of organizational support. Its market position is that of a regional player navigating a challenging operating environment characterized by regulatory pressures and liquidity constraints, requiring a focus on operational execution and financial stability to maintain its standing.
The company generated HKD 2.71 billion in revenue for the period. However, it reported a significant net loss of HKD -1.24 billion, indicating severe profitability challenges. Operating cash flow was positive at HKD 679.5 million, suggesting some core operational cash generation despite the reported bottom-line loss.
The substantial net loss and a diluted EPS of -HKD 0.28 reflect weak earnings power. The modest capital expenditure of HKD -1.3 million suggests a highly constrained investment environment, likely focused on preservation rather than growth, indicating poor capital efficiency in the current market cycle.
The balance sheet shows significant strain, with high total debt of HKD 22.79 billion vastly overshadowing a limited cash position of HKD 70.5 million. This substantial leverage and low liquidity position present considerable financial health risks and highlight a challenging debt burden.
Current financial results do not indicate positive growth trends. The company has a dividend per share of HKD 0, reflecting a conservative dividend policy that prioritizes capital preservation and debt management over shareholder returns given its loss-making status and leveraged position.
With a market capitalization of approximately HKD 946.7 million, the market is valuing the company at a significant discount to its stated revenue, reflecting deeply pessimistic expectations. The low beta of 0.218 suggests the stock is perceived as less volatile than the market, possibly due to its depressed price.
The company's strategic advantages are limited but may include its established operations and subsidiary status. The outlook remains challenging, contingent on a recovery in the Chinese property market and the company's ability to manage its substantial debt load and return to profitability.
Company DescriptionProvided Financial Data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |